Dose of prophylactic intravenous ephedrine during spinal anesthesia for cesarean section

J Clin Anesth. 2001 Aug;13(5):366-9. doi: 10.1016/s0952-8180(01)00284-7.

Abstract

Study objective: To compare the incidence of maternal hypotension associated with spinal anesthesia for cesarean section when 10-, 15-, or 20-mg prophylactic boluses of intravenous (IV) ephedrine are used.

Design: Prospective observational study.

Setting: Teaching hospital.

Patients: 108 women admitted for elective cesarean section.

Interventions: Spinal anesthesia was performed using hyperbaric bupivacaine 10 mg, sufentanil 2 microg, and morphine 0.2 mg (volume 4 mL). Ephedrine (10, 15, or 20 mg) was administered 2 minutes after the intrathecal injection. Maternal blood pressure was checked every 2 minutes. Hypotension was promptly treated with 5-mg ephedrine boluses.

Main results: Incidence of hypotension was significantly higher in women receiving a 10-mg prophylactic dose of ephedrine than in those receiving either a 15-mg or a 20-mg prophylactic dose of ephedrine [23/36 in the 10-mg ephedrine group vs. 13/36 and 10/36 in the 15-mg and 20-mg ephedrine groups, respectively (p< 0.05)].

Conclusion: In the conditions of this study, a single bolus of IV ephedrine with doses of either 15 or 20 mg decreased significantly the incidence of maternal hypotension as compared to a single 10-mg bolus of ephedrine.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Anesthesia, Epidural / adverse effects*
  • Anesthesia, Obstetrical / adverse effects*
  • Apgar Score
  • Blood Pressure / drug effects
  • Cesarean Section*
  • Ephedrine / administration & dosage
  • Ephedrine / therapeutic use*
  • Female
  • Heart Rate / drug effects
  • Humans
  • Hypotension / chemically induced
  • Hypotension / prevention & control*
  • Infant, Newborn
  • Injections, Intravenous
  • Pregnancy
  • Prospective Studies
  • Vasoconstrictor Agents / administration & dosage
  • Vasoconstrictor Agents / therapeutic use*

Substances

  • Vasoconstrictor Agents
  • Ephedrine